MedTrace Logo

Cross-condition Validation of the Steroid PRO

NCT06314451 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-03-20

No results posted yet for this study

Summary

Testing a questionnaire about treatment with steroids for skin, lung or gastric conditions

Conditions

  • Inflammatory Disease
  • Immune System Disorder
  • Gastrointestinal Diseases
  • Dermatologic Disease
  • Respiratory Disease

Interventions

OTHER

Cognitive Interview

The study involves a single cognitive interview with a researcher, either online, by telephone, or face-to-face. People who want to take part will be given information about the study and asked to give written consent. Then they will be asked to talk about the wording of the questionnaire and how relevant it is to them. Cognitive interviewing is recognized as a significant part of developing questionnaires for patient reported outcome measures (PROMs). The cognitive interviewing process used in PROM development will be adapted in this study to test the Steroid PRO in new disease populations. Cognitive interviewing will be carried out using pragmatic, light-touch interviews, underpinned by think aloud techniques and clean language principles.

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • University of the West of England

    lead OTHER

Principal Investigators

  • Joanna C Robson, FRCP PhD · University of the West of England

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06314451 on ClinicalTrials.gov